Showing 1 - 10 of 16
About one in ten patients are harmed during health care. This paper estimates the health, financial and economic costs of this harm. Results indicate that patient harm exerts a considerable global health burden. The financial cost on health systems is also considerable and if the flow-on...
Persistent link: https://www.econbiz.de/10011695017
Universal health coverage has been achieved in nearly all OECD countries, providing the population with access to a defined range of goods and services. This paper provides detailed descriptions of how countries delineate the range of benefits covered, including the role of health technology...
Persistent link: https://www.econbiz.de/10011578462
We assess the productivity growth of the English and Italian healthcare systems over the period from 2004 to 2011. The English (NHS) and the Italian (SSN) healthcare systems share many similar features, facilitating comparison: basic founding principles, financing, organization, management, and...
Persistent link: https://www.econbiz.de/10012941562
The aim of this article is to analyze the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and Price Controls (PC). We develop a model of adverse selection where a...
Persistent link: https://www.econbiz.de/10014212001
Physical inactivity and sedentary behaviours have been rising throughout the OECD in recent decades. Lack of physical activity and excessive sedentary behaviour are well-known risk factors for non-communicable diseases, such as heart diseases, stroke, diabetes, and osteoporosis. As such,...
Persistent link: https://www.econbiz.de/10012136141
In 2018, the Inter-American Development Bank and the OECD launched a survey to collect information on key health systems characteristics in Latin American and Caribbean (LAC) countries. This paper presents the information provided by 21 of these countries. It describes country-specific...
Persistent link: https://www.econbiz.de/10012136139
Across OECD countries, pharmaceutical spending reached around USD 800 billion in 2013, accounting for about 20% of total health spending on average when pharmaceutical consumption in hospital is added to the purchase of pharmaceutical drugs in the retail sector. This paper looks at recent trends...
Persistent link: https://www.econbiz.de/10011578412
This study covers “tapering scale” mechanism in hospital payments, i.e. mechanisms linking unit prices to the volume of services produced. This paper begins with an overview of hospital services and hospital payment methods in OECD countries, focusing more specifically on DRG-based payment....
Persistent link: https://www.econbiz.de/10011281250
Poor adherence to medications affects approximately half of the patient population, leading to severe health complications, premature deaths, and an increased use of healthcare services. The three most prevalent chronic conditions – diabetes, hypertension, and hyperlipidaemia – stand out...
Persistent link: https://www.econbiz.de/10011911474
This Working Paper examines income-related inequalities in health care service utilisation in OECD countries. It extends a previous analysis (Van Doorslaer and Masseria, 2004) to 2008-2009 for 13 countries, and adds new results for 6 countries, for doctor and dentist visits, and cancer...
Persistent link: https://www.econbiz.de/10009683133